A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer (Q34073969)
Jump to navigation
Jump to search
scientific article published on July 23, 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer |
scientific article published on July 23, 2010 |
Statements
A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer (English)
Jing Li
Ulka Vaishampayan
Felicity Harper
Pam Pemberton
Elisabeth I. Heath
1 reference
1 reference
1 reference
1 reference